ROMA vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

ROMA

54.1
AI Score
VS
ROMA Wins

ASTH

43.4
AI Score

Investment Advisor Scores

ROMA

54score
Recommendation
HOLD

ASTH

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ROMA ASTH Winner
Revenue 1.22M 3.18B ASTH
Net Income -3.50M 24.00M ASTH
Net Margin -287.8% 0.8% ASTH
Operating Income -3.83M 78.53M ASTH
ROE -36.4% 3.1% ASTH
ROA -35.1% 1.1% ASTH
Total Assets 9.97M 2.22B ASTH
Cash 884,396 429.47M ASTH
Current Ratio 22.34 1.40 ROMA
Free Cash Flow -2.54M 104.49M ASTH

Relative Price Performance (Last 90 Days)

ROMA 1M: +2.5% · 3M: +12.5% ASTH 1M: -4.0% · 3M: +5.3%

Current Technical Phase

ROMA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 50

RSI (14): 50.2 · Price: $8.99

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $39.35

Fundamentals Snapshot

Metric ROMA ASTH
Market Cap
Forward P/E 0.0 11.1
Trailing P/E 47.8
Revenue (TTM)
Revenue Growth -0.4% 0.5%
Gross Margin 0.1% 0.1%
Operating Margin -1.9% 0.0%
EPS -0.07 0.81
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ROMA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.